- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01257555
Evaluation of a Photopneumatic System for the Treatment of Acne
March 22, 2012 updated by: Solta Medical
The purpose of the study is to evaluate the safety and efficacy of a photopneumatic therapy for the treatment of acne and concomitant symptoms associated with the disease, including erythema.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The primary aims of the study will be to demonstrate the safety and efficacy of using a photopneumatic system for treatment of mild to moderate acne on the face or body - including neck, chest, and back - of up to 24 subjects.
To support this clinical assessment, the affected areas to be treated will be documented at baseline, at each subsequent treatment visit (up to 6 treatments), and at one (1) month and three (3) months following final treatment.
Study Type
Observational
Enrollment (Anticipated)
24
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Hayward, California, United States, 94545
- Solta Medical
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All genders and ethnic backgrounds.
No subjects from vulnerable categories (i.e.
minors, pregnant women, etc).
Description
Inclusion Criteria:
- Fitzpatrick skin type I-VI.
- Male or female.
- Subjects must be between 18 and 55 years of age.
- Subjects must have mild to moderate acne (defined as 15 or more inflammatory or non-inflammatory lesions).
- Subjects must read, understand, and sign the informed consent form.
- Subjects must be willing and able to comply with all follow-up requirements.
Exclusion Criteria:
- Subjects must not have active localized or systemic infections.
- Subjects must not have a compromised ability for wound healing, such as: malnutrition, steroid use, history of collagen vascular disease (e.g. lupus, scleroderma, history of keloid scar formation), atrophic dermatitis or immunologic abnormalities such as vitiligo.
- Subjects must not have received microdermabrasion within one (1) month prior to enrollment.
- Subjects must not have received immunosuppressive medication(s) one (1) month prior to enrollment.
- Subjects must not have received laser or light treatment within the last three (3) months.
- Subjects must not have received dermabrasion, TCA peel greater than 20%, botulinum toxin type A, dermal fillers, photodynamic therapy (PDT), or cosmetic surgery within the last six (6) months .
- Subjects must not be currently taking or have used isotretinoin (e.g. Accutane) within six (6) months prior to enrollment.
- Subjects must agree to refrain from using cosmeceutical agents or topical agents during the course of the study, except as directed by study investigators.
- Subjects must not have had previous ablative laser treatment.
- Subjects must refrain from excessive sun exposure during participation in this study.
- Subjects must not have any condition that results in photosensitivity or be taking any medication containing aminolevulinic acid (E.g. Levulan).
- Subjects must not be a current or past smoker of cigarettes and/or cigars.
- Subjects must not be pregnant.
- Any condition or situation that would prevent the subject from safely completing all protocol requirements for participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Treatment Group
|
Use of intense pulsed light (photo) in combination with vacuum technology (pneumatic) to treat mild to moderate acne.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (Actual)
September 1, 2011
Study Completion (Actual)
September 1, 2011
Study Registration Dates
First Submitted
December 8, 2010
First Submitted That Met QC Criteria
December 8, 2010
First Posted (Estimate)
December 9, 2010
Study Record Updates
Last Update Posted (Estimate)
March 26, 2012
Last Update Submitted That Met QC Criteria
March 22, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Other Study ID Numbers
- 10-116-CF-I
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild to Moderate Acne
-
DarierUnknown
-
Károli Gáspár University of the Reformed Church...University of TorontoCompletedMild to Moderate Psychopathological SymptomsHungary
-
Károli Gáspár University of the Reformed Church...University of TorontoCompletedMild to Moderate Psychopathological SymptomsHungary
-
NestléCompletedMild to Moderate Levels of StressSwitzerland
-
Tishreen UniversityCompletedMild to Moderate Anterior Mandibular Segment CrowdindSyrian Arab Republic
-
Beer, Kenneth R., M.D., PAMedicis Pharmaceutical CorporationCompletedMild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital RhytidsUnited States
-
Ulthera, IncUniversity of Texas Southwestern Medical CenterCompletedMild to Moderate Skin Laxity on Cheek | Mild to Moderate Skin Laxity on Upper Neck | Mild to Moderate Subcutaneous Fat on Cheek | Mild to Moderate Subcutaneous Fat on Upper Neck
-
San Diego Veterans Healthcare SystemCongressionally Directed Medical Research ProgramsCompletedPTSD With a History of Mild to Moderate TBIUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingModerate to Severe Acne VulgarisChina
-
PollogenLumenis Be Ltd.RecruitingModerate to Severe Acne VulgarisUnited States
Clinical Trials on Photopneumatic therapy
-
University of Alabama at BirminghamCompleted
-
Mennallah Ahmed Mohamed Anwar ElgendyNot yet recruiting
-
Spaulding Rehabilitation HospitalActive, not recruiting
-
Istanbul Medipol University HospitalCompleted
-
St. Jude Children's Research HospitalCompletedStem Cell Transplant | Bone MarrowUnited States, Canada
-
Universidad de ZaragozaCompletedPlagiocephaly | Plagiocephaly, Nonsynostotic | Plagiocephaly, PositionalSpain
-
National Taiwan University HospitalNot yet recruitingAutism | Language Delay | Speech Disorders in Children
-
Hospital for Special Surgery, New YorkActive, not recruiting
-
Maastricht Radiation OncologyUniversity of Pennsylvania; Philipps University Marburg Medical Center; University...CompletedCarcinoma, Squamous Cell of Head and NeckNetherlands